Pharmacy, Natural & Health Sciences

About Pharmacogenomics

Welcome from the Program Director

About Pharmacogenomics

Pharmacogenomics (PGx), the study of a patient’s response to medications relative to their genetics, is a rapidly expanding component of precision medicine. The ability to look at an individual’s DNA/genetics and use that information along with all other pertinent data, to guide drug and/or drug dose selection can lead to more successful treatment, and help reduce adverse drug events. Approximately 50 percent of patients receiving particular medications do not respond optimally. Additionally, over the last number of years, we have seen an increase in the number of serious adverse drug events, with more than 1,000,000 serious events and more than 180,000 deaths annually. Along with other patient information, there is a role for pharmacogenomics in helping to improve and optimize patient medication therapy.

With the launch of the nation’s first master’s program in pharmacogenomics in 2016, Manchester University acted upon the need for education of applied scientists and clinicians in PGx. The Master of Science in Pharmacogenomics Program is a comprehensive program aimed to produce the applied scientist with opportunities for careers in the PGx laboratory industry, translational companies, and health care systems. The Graduate Certificate in Pharmacogenomics, introduced in 2020, is aimed at clinicians, to help them optimize drug therapy and hone their pharmacotherapy expertise. The programs are approved by the Higher Learning Commission.

Accreditation

The Manchester University Master of Science in Pharmacogenomics Program and Graduate Certificate in Pharmacogenomics are accredited by the Higher Learning Commission of the North Central Association of Colleges and Schools.

Mission

The Master of Science in Pharmacogenomics Program and Graduate Certificate in Pharmacogenomics graduates individuals of ability and conviction who benefit society through the application of pharmacogenomics in precision medicine.

Advisory Board

Our PGx Advisory Board is comprised of industry partners and thought leaders in the genomics and health care industries.